Author:
Fahrner Robert L.,Blank Gregory S.
Reference19 articles.
1. Afeyan NB, Gordon NF, Mazaroff I et al., (1990) Flow-through particles for the high-peformance liquid chromatographic seaparation of biomolecules: perfusion chromatography. Chrom 519: 1–29.
2. Afeyan, N.B., Fulton, S.P., Gordon, N et al. (1990) Perfusion chromatography: an approach to purifying biomolecules. Bio/ Technology 8: 203–206
3. Afeyan, N.A., Fulton, S.P., Regnier, F.E. (1991) Perfusion chromatography packing materials for proteins and peptides. J Chrom 544: 267–279
4. Carter, P., Presta, L., Gorman, C.M et al. (1992) Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Nati Acad Sci USA 89: 4285–4289
5. Anderson, D.R., Grillo-Lopez, A., Varns, C et al. (1996) Targeted anti-cancer therapy using rituximab, a chimeric antiCD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin’s B-cell lymphoma. Biochemical Society Transactions 25: 705–708